Royal Bank Of Canada Praxis Precision Medicines, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.8 - $4.98 $1,689 - $10,517	-2,112 Reduced 44.18%	2,668 $2,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $2.49 $7,943 - $10,520	4,225 Added 761.26%	4,780 $11,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.77 $855 - $1,631	342 Added 160.56%	555 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $3,209 - $20,797	-1,834 Reduced 89.59%	213 $1,000
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $47,170 - $93,739	-4,620 Reduced 69.3%	2,047 $21,000

Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $51,252 - $70,303	3,058 Added 84.73%	6,667 $132,000
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $25,458 - $43,676	1,936 Added 115.72%	3,609 $67,000
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $30,582 - $55,292	1,673 New	1,673 $31,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.